Back to Search Results


Address Details:
7 Frome Road
ADELAIDE, SA 5000
AUSTRALIA Map
www.sapathology.sa.gov.au

Contact Details:
Mr Jason Graefling
+61(08) 82223137

Availability:
Services available to external clients
Supervision:
GY (General)

Attached Departments:

* Anatomical Pathology
* Cellular Therapies Laboratory
* Cellular Therapies Laboratory
* Chemical Pathology
* Chemical Pathology
* Complex Inherited Disorders
* Cytogenetics (Cancer) Laboratory
* Familial Cancer Laboratory
* Immunology
* Leukaemia Unit
* Metabolic Laboratory
* Microbiology and Infectious Diseases
* Molecular Genetics
* Molecular Oncology
* Paediatric Laboratory
* Sequencing Centre
* Toxicology Laboratory

  View and Print Scope of Accreditation Printable version

Note: Not all of the columns of the scope of accreditation displayed include data.
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.


  • Anatomical Pathology

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions
    Cervical tissue;
    Cytological examination; Review and reporting of cervical cytological material;

    Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions
    Vaginal tissue;
    Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples;

    Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy
    Other body fluids; Sputum; Urine; Washings or brushings from other sites;
    Cytological examination; Review and reporting of cytology samples;

    Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes
    Anus smears; Lip smears; Mouth smears; Nipple discharge; Nose smears; Skin smears;
    Cytological examination; Review and reporting of cytology samples;

    Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy
    Fine needle aspirates (FNA);
    Cytological examination; Review and reporting of fine needle aspiration samples;

    Anatomical pathology - Cytopathology - Testing for the National Cervical Screening Program
    Liquid based cytology specimens from cervix;
    Human papilloma virus; Cytological examination; Review and reporting of cervical cytological material;

    Anatomical pathology - Tissue pathology - Examination of biopsy material
    Formalin fixed tissue; Fresh tissue;
    Review and reporting of biopsy material to identify or exclude morphological abnormalities;


    Muscle and nerve only


    Anatomical pathology - Tissue pathology - Examination of biopsy material by electron microscopy
    Formalin fixed tissue;
    Review and reporting of biopsy material to identify or exclude ultra-structural morphological abnormalities
    ;

    Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation
    Fixed cytological smears;
    Detection of antigenic targets - Various;

    Infertility and pregnancy tests including assisted reproductive technology - Semen analysis (other than post vasectomy)
    Semen;
    Morphology; Motility; Sperm number; Volume;



  • Cellular Therapies Laboratory
  • Cellular Therapies Laboratory

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells
    Bone marrow; Haemopoietic progenitor cells;
    Processing; Storage - Includes freezing/thawing;

    Product received from Royal Adelaide Hospital Haematology Day Centre and WCH Apheresis Services



    Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cells
    Haemopoietic progenitor cells;
    Enumeration of CD34+ cells;

    Product received from Royal Adelaide Hospital Haematology Day Centre and WCH Apheresis Services





  • Chemical Pathology
  • Chemical Pathology

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals
    Plasma; Serum;
    Fentanyl; Methadone; Morphine; Oxycodone;

    Chemical pathology - Biogenic amines
    Plasma;
    Metanephrine;


    Urine;
    Catecholamines; Metanephrine;



    4-Hydroxy-3-methoxymethamphetamine (HMMA); 5-Hydroxyindoleacetic acid (5-HIAA); Homovanillic acid (HVA);

    Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring
    Plasma; Serum;
    5-Flucytosine; 6-Mercaptopurine; 6-Thioguanine;



    Clozapine; Olanzapine; Quetiapine;



    Amiodarone; Aripiprazole; Flecainide; Lamotrigine; Levetiracetam; Mycophenolate; Paliperidone; Perhexiline; Risperidone;


  • Complex Inherited Disorders

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Molecular genetics - Bioinformatic analysis
    DNA sequences;
    Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation;

    Molecular genetics - DNA sequencing
    Blood;
    DNA sequence analysis;


  • Cytogenetics (Cancer) Laboratory

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Cytogenetics - Detection of defined, unbalanced chromosomal abnormalities by in-situ hybridisation techniques
    Blood; Bone marrow; Tissues;
    Cytogenetic analysis and reporting;

    Cytogenetics - Karyotype detection of balanced and/or unbalanced chromosome abnormalities
    Blood; Bone marrow; Tissues;
    Cytogenetic analysis and reporting;



    Cytogenetic analysis and reporting;


  • Familial Cancer Laboratory

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Whole exome sequencing studies for inherited (germline) DNA/RNA changes
    Blood;
    Acute myeloid leukaemia RUNX1; Bannayan-Riley-Ruvalcaba syndrome; Cowdens; Emberger syndrome; Familial adenomatous polyposis; Fanconi anaemia; Gastrointestinal stroma tumour; Hemangioblastoma; Hereditary diffuse gastric cancer; Immunodeficiency; Juvenile polyposis; Lynch syndrome; Macrocephaly PTEN gene mutation; Maturity onset diabetes of the young (MODY); Multiple endocrine neoplasia type 1 (MEN1); Multiple endocrine neoplasia type 2 (MEN2); Neurofibromatosis; Paragangliomas; Phaeochromocytoma; Primary cilary dyskenesis; Renal clear cell carcinoma; Retinoblastoma; Scwhannomatosis; TEN Hamartoma tumour syndrome; Von Hippel Lindau disease;

    Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changes
    Amniotic fluid; Blood; Buccal swabs; Chorionic villus;
    Acute myeloid leukaemia RUNX1; Bannayan-Riley-Ruvalcaba syndrome; Cowdens; Emberger syndrome; Familial adenomatous polyposis; Gastrointestinal stroma tumour; Hemangioblastoma; Hereditary diffuse gastric cancer; Lynch syndrome; Macrocephaly PTEN gene mutation; Multiple endocrine neoplasia type 1 (MEN1); Multiple endocrine neoplasia type 2 (MEN2); Neurofibromatosis; Paragangliomas; Phaeochromocytoma; Renal clear cell carcinoma; Retinoblastoma; Scwhannomatosis; TEN Hamartoma tumour syndrome; Von Hippel Lindau disease;


  • Immunology

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation
    Formalin fixed paraffin embedded tissue sections;
    Detection of antigenic targets - Various;

    Chemical pathology - Further investigation of renal and/or hepatic function
    Plasma; Serum;
    Tryptase;

    Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping)
    Blood;
    HLA-DR1; HLA-DR4;


    Blood; Bone marrow; Cerebrospinal fluid (CSF); Disaggregated tissues specimen; Fresh tissue; Lavage; Serous fluid;
    CD1a; CD2; CD3; CD4; CD5; CD7; CD8; CD10; CD11b; CD11c; CD13; CD14; CD15; CD16; CD19; CD20; CD21; CD22; CD23; CD24; CD25; CD27; CD28; CD30; CD33; CD34; CD38; CD41; CD45; CD45RA; CD45RO; CD56; CD57; CD58; CD61; CD64; CD65; CD71; CD81; CD103; CD117; CD123; CD138; CD197; CD235a; FMC7; HLA-DR antigen; Immunoglobulin G (IgG); Immunoglobulin M (IgM); Kappa light chains; Lambda light chains; T-cell receptor γδ (TCRgd); T-cell receptor (TCR) variable β; T-cell receptor aβ (TCRab);

    Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies
    Plasma; Serum;
    Anti-histone antibodies (AHA); Anti-intrinsic factor antibodies (IF);



    Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA);



    Anti-liver cytosol antibodies (LC-1); Anti-mitochondrial antibodies (AMA, AMA M1, AMA M2); Anti-soluble liver antigen/liver-pancreas antibodies (SLA/LP);



    Anti-cardiolipin antibodies (ACA); Anti-glomerular basement membrane antibodies (anti-GBM); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-thyroid peroxidase antibodies (TPO);



    Anti-β-2-glycoprotein 1 antibodies;



    Anti-thyrotropin receptor antibodies (TSHR);



    Anti-RNA polymerase III antibodies (ARA, RNAP);



    Anti-neuronal antibodies; Anti-Purkinje cell antibodies (PCA2);



    Anti-gastric parietal cell antibodies (GPC/PCA); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1, AMA M2); Anti-smooth muscle antibodies (SMA);

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing (purified native and/or recombinant allergens))
    Serum;
    β-Lactoglobulin - Milk; Api m1 phospholipase A2 - Honey bee; Ara h2 - Peanut; Pol d5 - European paper wasp; Ves v5 - Common wasp;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens)
    Serum;
    Amoxicilloyl group; Ampicilloyl group; Cefaclor; Morphine; Penicilloyl G; Penicilloyl V; Pholcodine; Protamine; Suxamethonium (succinylcholine);

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens)
    Serum;
    Budgerigar droppings; Budgerigar feathers; Cat dander; Cow dander; Dog dander; Guinea pig epithelium; Horse dander; Mouse urine proteins; Rabbit epithelium; Rat epithelium; Rat urine proteins;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [additives] allergens)
    Serum;
    Guar gum (E412);

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens)
    Serum;
    Chicken; Egg; Egg white; Egg yolk;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens)
    Serum;
    Blue mussel; Codfish; Crab; Lobster; Oyster; Pacific squid; Salmon; Scallop; Shrimp; Tuna;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens)
    Serum;
    Apple; Apricot; Avocado; Banana; Bromelain; Garlic; Kiwi; Mandarin (tangerine, clementine, satsumas) citrus; Mango; Melon; Onion; Orange citrus; Peach; Pineapple; Potato; Strawberry; Tomato; Watermelon;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens)
    Serum;
    Galactose-α-1,3-galactose; Beef; Mutton; Pork;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens)
    Serum;
    Casein; Milk;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens)
    Serum;
    Cacao; Chocolate; Omega-5-gliadin; Yeasts;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens)
    Serum;
    Almond; Barley; Brazil nut; Cashew nut; Hazelnut; Lentil; Lupin seed; Macadamia nut; Maize; Oat; Peanut; Pecan nut; Pinenut; Pistachio; Rice; Rye; Sesame seed; Soy bean; Walnut; Wheat;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [spices] allergens)
    Serum;
    Chilli pepper; Mustard;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens)
    Serum;
    Bahia grass; Bermuda grass; Brome grass; Couch grass; Cultivated wheat; Johnson grass; Profilin; Rye grass; Timothy grass; Velvet grass;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens)
    Serum;
    German cockroach; Mosquito;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens)
    Serum;
    Alternaria alternata; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Aspergillus terreus; Cladosporium herbarum; Malassezia spp.; Penicillium chrysogenum (formerly Penicillium notatum); Pityrosporum orbiculare; Setomelanomma rostrata (Helminthosporium halodes); Trichophyton rubrum;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens)
    Serum;
    Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite; Glycyphagus domesticus storage mite; Lepidoglyphus destructor storage mite; Tyrophagus putrescentiae storage mite;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens)
    Serum;
    α-Amylase; Chlorhexidine; Formaldehyde/formalin; Isocyanate HDI (hexamethylene diisocyanate, 1,6-hexamethylene diisocyanate); Latex;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens)
    Serum;
    Acacia; Australian pine; Eucalyptus; Melaleuca; Olive; Plane tree; Silver birch; Wattle; White pine; Willow salix;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens)
    Serum;
    Bull ant - Myrmecia forficata; Bull ant - Myrmecia nigriceps; Bull ant - Myrmecia pyriformis; Common wasp (yellow jacket) venom; Honey bee venom; Jumper ant; Paper wasp venom;

    Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens)
    Serum;
    Chenopodium; Goosefoot; Lamb’s quarters; Plantain - English; Russian thistle; Saltwort (prickly); Sheep sorrel; Wall pellitory;

    Immunopathology - Quantitative and/or qualitative investigation of proteins
    Serum;
    Protein classes;


    Plasma; Serum;
    Characterisation of paraproteins; Detection and amount of paraproteins;



    Detection and quantitation of free kappa and lambda light chains;


    Faeces;
    Calprotectin;


    Urine;
    Detection of Bence Jones proteins;



    Characterisation of cryoglobulins; Cryofibrinogen; Cryoglobulins;

    Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses
    Plasma; Serum;
    Total immunoglobulin A;



    Total immunoglobulin G;



    Total immunoglobulin E;

    Immunopathology - Single HLA antigen typing
    Blood;
    HLA-B27;



    HLA-B5701;

    Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation
    Blood;
    Mycobacterial antigen lymphocyte stimulation;

    Molecular genetics - Screening for an unknown mutation - Targeted genes
    Blood;
    Thiopurine methyltransferase (TPMT) genotyping;



    Coeliac disease;


  • Leukaemia Unit

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes
    Blood; Bone marrow;
    CSF3R and SETBP1 mutation test; Leukaemic gene rearrangements; Quantitative calculation of p210 positive BCR/ABL1 transcripts;


  • Metabolic Laboratory

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Chemical pathology - Analysis of calculus
    Calculi;
    Calcium; Magnesium; Oxalate; Phosphate;

    Chemical pathology - Detection and/or quantitation of tumour markers
    Plasma; Serum;
    β-2-Microglobulin (B2M);

    Chemical pathology - Detection and/or quantitation of tumour markers - Testing for the National Bowel Cancer Screening Program
    Faeces;
    Blood;

    Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests)
    Serum;
    Growth hormone; Insulin-like growth factor 1 (IGF-1, somatomedin C);


    Plasma; Serum;
    Erythropoietin (EPO); Gastrin;

    Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia
    Serum;
    Lipoprotein subclasses;

    Chemical pathology - Further investigation of renal and/or hepatic function
    Serum;
    Alkaline phosphatase isoenzymes; Lactate dehydrogenase (LDH) isoenzymes;



    α-1-Antitrypsin; Caeruloplasmin; Haptoglobins;



    α-1-Antitrypsin phenotype;


    Faeces;
    α-1-Antitrypsin;

    Chemical pathology - Investigation and determination of hepatic, cardiac, bone, lipid, renal, skeletal muscle and other profiles and metabolic studies
    Serum;
    Acid phosphatase;



    Angiotensin converting enzyme (ACE);


    Plasma;
    45 Calcium absorption;


    Blood; Plasma;
    Cholinesterase;


    Cerebrospinal fluid (CSF);
    Albumin;

    Chemical pathology - Investigation of malabsorption - Quantitation of solid tissue enzymes
    Intestinal tissue;
    Lactase; Maltase; Sucrase;

    Chemical pathology - Quantitation of precursor and intermediary metabolites
    Urine;
    Oxalate;

    Chemical pathology - Quantitation of vitamins
    Serum;
    1,25-Dihydroxyvitamin D;



    25-Hydroxyvitamin D;



    Ascorbic acid (vitamin C);


    Blood;
    Pyridoxine (vitamin B6); Thiamine (vitamin B1);

    Chemical pathology - Trace element analysis
    Plasma; Serum;
    Aluminium; Chromium; Cobalt; Copper; Magnesium; Selenium; Zinc;


    Blood;
    Cadmium; Lead; Magnesium; Manganese; Mercury;


    Liver;
    Copper;



    Iron;


    Urine;
    Arsenic; Cadmium; Chromium; Cobalt; Copper; Iodine; Lead; Magnesium; Manganese; Mercury; Thallium; Zinc;

    Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays)
    Blood;
    Glucose-6-phosphate dehydrogenase (G6PD);

    Immunopathology - Quantitative and/or qualitative investigation of proteins
    Other body fluids;
    β-2-Transferrin;


    Cerebrospinal fluid (CSF);
    Detection of oligoclonal bands;

    Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses
    Cerebrospinal fluid (CSF);
    Total immunoglobulin G;


  • Microbiology and Infectious Diseases

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Microbiology - Bacteriology - Detection of pathogenic bacteria
    Isolates;
    Legionella pneumophila;


    Respiratory specimens;
    Legionella pneumophila;

    Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria)
    Genital swabs; Urine;
    Mycoplasma genitalium;


    Eye swabs; Genital swabs; Liquid based cytology specimens; Urine;
    Chlamydia trachomatis; Neisseria gonorrhoeae;

    Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria)
    Bacterial isolates;
    Mycobacterium spp.;


    Bacterial isolates; Respiratory specimens;
    Mycobacterium rifampicin resistance rpoB; Mycobacterium tuberculosis;

    Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites)
    Genital swabs; Urine;
    Trichomonas vaginalis;

    Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses)
    Plasma;
    HIV-1 RNA;


    Plasma; Serum;
    Hepatitis C viral RNA;



    Hepatitis B (HBV) DNA;


    Liquid based cytology specimens;
    Human papilloma virus ;

    Microbiology - Molecular biology - Microbial genotyping
    Plasma;
    HIV-1 sequencing for drug resistance;


    Plasma; Serum;
    Hepatitis C (HCV) subtypes;

    Microbiology - Mycobacteriology - Detection and identification of mycobacteria
    Isolates;
    Mycobacteria antibiotic susceptibility;



    Mycobacteria identification;



    Mycobacteria antibiotic susceptibility;



    Mycobacteria antibiotic susceptibility;



    Mycobacteria identification;


    Blood; Bone marrow;
    Mycobacteria identification;


    Other body fluids; Respiratory specimens; Tissues;
    Mycobacteria identification;


    Other body fluids; Respiratory specimens; Tissues; Urine;
    Mycobacteria identification; Other pathogenic bacteria to genus level or species level;



    Mycobacteria identification;


    Urine;
    Mycobacteria identification;

    Microbiology - Mycology - Detection, isolation and identification of yeasts and fungal elements
    Isolates;
    Fungi susceptibility; Yeast susceptibility;



    Yeast susceptibility;



    Fungi identification; Yeasts identification;



    Fungi identification; Yeasts identification;


    Blood;
    Fungi identification; Yeasts identification;


    Cerebrospinal fluid (CSF); Fluids; General swabs; Isolates; Nails; Respiratory specimens; Skin scrapings; Tissues;
    Fungi identification; Yeasts identification;


    Cerebrospinal fluid (CSF); Fluids; General swabs; Nails; Respiratory specimens; Skin scrapings; Tissues;
    Fungi identification; Yeasts identification;

    Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation
    Plasma; Serum;
    Hepatitis C (HCV); HIV 1/2 antibodies; HIV 1/2 antigen; HTLV I/II;


  • Molecular Genetics

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes
    Blood;
    β-Thalassaemia (β-thalassemia); Alpha-thalassaemia; Autoimmune polyendocrinopathy syndrome type 1; Factor V Leiden; Factor XIII deficiency; Haemochromatosis; Haemophilia A; Haemophilia B; Haemophilia C; Prothrombin variant; Von Willebrand disorder;

    Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes
    Blood;
    Copy number variation (CNV) chimerism test; Quantitation of donor and recipient bone marrow derived cells in a transplant recipient;

    Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes
    Formalin fixed paraffin embedded tissue sections;
    Indels; Single nucleotide variants (SNVs);

    Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Whole exome sequencing for non-inherited (somatic) DNA/RNA changes
    Blood;
    Fusion genes; Indels; Novel isoforms; Single nucleotide variants (SNVs);

    Molecular genetics - Heterozygous loci determinations
    Blood; Chorionic villus; Products of conception (POC); Tissues;
    Nucleic acid analysis for specific variants;

    Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted panels for inherited (germline) DNA/RNA changes
    Blood;
    Copy number variation (CNV); Indels; Single nucleotide variants (SNVs);

    Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Whole exome sequencing studies for inherited (germline) DNA/RNA changes
    Blood;
    Copy number variation (CNV); Indels; Single nucleotide variants (SNVs);

    Molecular genetics - Predictive genetic testing - Targeted panels for inherited (germline) DNA/RNA changes
    Blood;
    β-Thalassaemia (β-thalassemia); Alpha-thalassaemia; Haemophilia A; Haemophilia B; Haemophilia C;



    Haemophilia A; Haemophilia B; Haemophilia C;

    Molecular genetics - Prenatal genetic testing (excluding non-invasive prenatal [genetic] screening)
    Amniotic fluid; Chorionic villus tissue; Cultured amniotic fluid cells; Cultured chorionic villus cells;
    β-Thalassaemia (β-thalassemia); Alpha-thalassaemia; Haemophilia A; Haemophilia B;


  • Molecular Oncology

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes
    Blood; Bone marrow; Formalin fixed paraffin embedded tissue sections;
    Blood borne tumours; Breast cancer; Solid tumours;

    Molecular genetics - Heterozygous loci determinations
    Blood; Tissues;
    Blood borne tumours;


  • Paediatric Laboratory

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring
    Serum;
    Itraconazole; Posaconazole; Sulthiame; Voriconazole;

    Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests)
    Serum;
    17α-Hydroxyprogesterone ;

    Chemical pathology - Investigation of porphyria
    Blood; Plasma cells;
    Total porphyrins;


    Faeces; Urine;
    Porphyrin isomers; Total porphyrins;


    Urine;
     δ-Aminolevulinic acid (δ-ALA); Porphobilinogen (PBG);

    Chemical pathology - Quantitation of vitamins
    Serum;
    Carotenoids; Retinol (vitamin A); Tocopherol (vitamin E);


  • Sequencing Centre

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Molecular genetics - DNA sequencing
    Purified PCR product;
    DNA sequence analysis;


  • Toxicology Laboratory

  • ISO 15189 (2012)
    Human Pathology
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals
    Urine;
    Ethylglucuronide (ETG); Ethyl sulfate;


    ISO 15189 (2012)
    Legal
    | Last Activity Date: 06-Aug-2019 |  Medicare Expiry Date: 31-Dec-2020 |
    SERVICEPRODUCTDETERMINANTTECHNIQUEPROCEDURELIMITATION/RANGE
    Medico legal drug testing AS 4760, section 4 Laboratory initial testing
    Oral fluid;
    δ-9-Tetrahydrocannabinol (THC); Amphetamine type substances; Cocaine; Cocaine metabolites;

    Medico legal drug testing AS 4760, section 5 Confirmatory testing procedures
    Oral fluid;
    δ-9-Tetrahydrocannabinol (THC); 3,4-Methylenedioxyamphetamine (MDA); 3,4-Methylenedioxymethamphetamine (MDMA); 6-Acetylmorphine; Alprazolam; Amphetamines; Benzoylecgonine (ecgonine benzoate); Buprenorphine; Clonazepam; Cocaine; Codeine; Diazepam; Ecgonine methyl ester; Flunitrazepam; Lorazepam; Methadone; Methyl amphetamine; Midazolam; Morphine; Nitrazepam; Nordiazepam; Oxazepam; Oxycodone; Temazepam;

    Medico legal drug testing AS/NZS 4308, section 2 Specimen collection, storage, handling and dispatch
    Urine;
    Colour; Creatinine; pH; Temperature;

    Various Collection Centres



    Medico legal drug testing AS/NZS 4308, section 3 General laboratory requirements
    Urine;
    General laboratory requirements as described in AS/NZS 4308;

    Medico legal drug testing AS/NZS 4308, section 4 Laboratory screening procedures
    Urine;
    Amphetamine type substances; Benzodiazepines; Cannabis metabolites; Cocaine metabolites; Opiates;

    Medico legal drug testing AS/NZS 4308, section 5 Laboratory confirmatory procedures
    Urine;
    α-Hydroxy-alprazolam; 6-Acetylmorphine; 7-Amino-clonazepam; 7-Amino-flunitrazepam; 7-Amino-nitrazepam; 11-nor-δ-9-Tetrahydrocannabinol-9-carboxylic acid; Amphetamines; Benzoylecgonine (ecgonine benzoate); Benzylpiperazine (BZP, 1-benzylpiperazine); Buprenorphine; Codeine; Diazepam; Ecgonine methyl ester; Ephedrine; Methadone; Methyl amphetamine; Methylenedioxyamphetamine; Methylenedioxymethylamphetamine; Morphine; Nordiazepam; Oxazepam; Phentermine; Pseudoephedrine (PSE); Temazepam;